News & Events

Recent News View All News

Mar 27, 2025 8:05am EDT

Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation

Mar 10, 2025 8:05am EDT

Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors

View All News

Corporate Presentation

March 2025

Upcoming Events View All Events

May 22, 2025 7:30 am PDT

2025 Annual Meeting of Stockholders

View IR Calendar